Literature DB >> 8374095

Epidemiology of precancerous gastric lesions.

W C You1, Y S Chang.   

Abstract

Research over the past several decades has revealed that the major subtype of gastric cancer (intestinal gastric cancer) is an end result of a multistage transformation of the gastric mucosa over many years and that this process is mainly determined by environmental factors. Epidemiologic studies on precancerous gastric lesions, including a large population-based study of the natural history and aetiology of precancerous gastric lesions conducted in Shandong, China, are reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374095     DOI: 10.1111/j.1440-1746.1993.tb01531.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

Review 1.  Pathology of gastric intestinal metaplasia: clinical implications.

Authors:  Pelayo Correa; M Blanca Piazuelo; Keith T Wilson
Journal:  Am J Gastroenterol       Date:  2010-03       Impact factor: 10.864

2.  Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study.

Authors:  Dan Li; Marita C Bautista; Sheng-Fang Jiang; Paras Daryani; Marilyn Brackett; Mary Anne Armstrong; Yun-Yi Hung; Debbie Postlethwaite; Uri Ladabaum
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

3.  NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population.

Authors:  Zhe-Xuan Li; Yu-Mei Wang; Fu-Bing Tang; Lian Zhang; Yang Zhang; Jun-Ling Ma; Tong Zhou; Wei-Cheng You; Kai-Feng Pan
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Dynamic observation and analysis of metabolic response to moxibustion stimulation on ethanol-induced gastric mucosal lesions (GML) rats.

Authors:  Miao-Sen Huang; Yuan Zhang; Cai-Chun Liu; Lin-Yu Lian; Jia-Cheng Shen; Qi-da He; Ying-Jie Wang; Long-Bin Zhang; Mi Liu; Zong-Bao Yang
Journal:  Chin Med       Date:  2019-10-15       Impact factor: 5.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.